Barclays
VTVT icon

Barclays’s vTv Therapeutics VTVT Stock Holding History

Barclays’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$126K Buy
+4,098
New +$133K ﹤0.01% 4206
2026
Q2 		– Sell
-36
Closed -$1.43K – 5666
2026
Q1 		$1.43K Buy
+36
New +$1.31K ﹤0.01% 4882
2021
Q4 		– Sell
-38
Closed -$2K – 4778
2021
Q3 		$2K Sell
38
-43
-53% -$3.24K ﹤0.01% 4679
2021
Q2 		$7K Sell
81
-167
-67% -$16.9K ﹤0.01% 4718
2021
Q1 		$28K Buy
248
+159
+179% +$15.6K ﹤0.01% 4311
2020
Q4 		$7K Sell
89
-27
-23% -$2.07K ﹤0.01% 4774
2020
Q3 		$9K Sell
116
-15
-11% -$1.32K ﹤0.01% 5029
2020
Q2 		$12K Buy
131
+90
+220% +$8.89K ﹤0.01% 5302
2020
Q1 		$3K Sell
41
-3,148
-99% -$303K ﹤0.01% 5998
2019
Q4 		$217K Buy
+3,189
New +$194K ﹤0.01% 4975
2019
Q3 		– Sell
-116
Closed -$7K – 7165
2019
Q2 		$7K Sell
116
-584
-83% -$35.1K ﹤0.01% 6637
2019
Q1 		$48K Hold
700
– – ﹤0.01% 5910
2018
Q4 		$74K Buy
700
+550
+367% +$50.9K ﹤0.01% 5246
2018
Q3 		$5K Sell
150
-223
-60% -$10.5K ﹤0.01% 6799
2018
Q2 		$23K Buy
373
+321
+617% +$23.7K ﹤0.01% 6111
2018
Q1 		$8K Hold
52
– – ﹤0.01% 6712
2017
Q4 		$13K Buy
52
+40
+333% +$8.97K ﹤0.01% 6459
2017
Q3 		$3K Sell
12
-11
-48% -$2.19K ﹤0.01% 6612
2017
Q2 		$5K Buy
23
+19
+475% +$3.96K ﹤0.01% 6252
2017
Q1 		$1K Sell
4
-8
-67% -$1.82K ﹤0.01% 6642
2016
Q4 		$2K Buy
12
+11
+1,100% +$2.53K ﹤0.01% 6380
2016
Q3 		$0 Buy
+1
New +$241 ﹤0.01% 6816

Other funds holding VTVT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Strengthening Families & Communities LLC
Strengthening Families & Communities LLC Boston, Massachusetts $459M AUM 29.64% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Barclays's VTVT Position: Q3 2026 in Review

Barclays opened a new position in vTv Therapeutics (VTVT) in Q3 2026: 4,098 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #4206 among its holdings. This is a return to the name: Barclays previously reported a position in VTVT as recently as Q1 2026.

Barclays first reported a position in VTVT in Q3 2016 and has held it in 22 quarters since. The position peaked at $217K in Q4 2019. 11 funds tracked by Wall St. Rank hold VTVT as of Q3 2026.

  • Barclays held 4,098 shares of vTv Therapeutics worth $126K as of Q3 2026.
  • vTv Therapeutics was a new Barclays position in Q3 2026.
  • vTv Therapeutics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4206 holding.
  • Barclays first reported a position in vTv Therapeutics in Q3 2016 and has held it in 22 quarters since.
  • Barclays's vTv Therapeutics position peaked at $217K in Q4 2019.
  • 11 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.